1. Maintenance Therapy in HER2-Negative Metastatic Breast Cancer: A New Approach for an Old Concept

   • Eva Ciruelos
   • José Manuel Pérez-García
   • Juan de la Haba-Rodriguez

   Review Article 03 May 2019 Pages: 595 - 606

   

2. Melatonin and Multiple Sclerosis: From Plausible Neuropharmacological Mechanisms of Action to Experimental and Clinical Evidence

   • Mahshid Yeganeh Salehpour
   • Adriano Mollica
   • Mohammad Hosein Farzaei

   Review Article 03 May 2019 Pages: 607 - 624

   

3. A Real-World Analysis of Prescribing Patterns and Non-persistence of Anti-TNFα Therapy for Inflammatory Bowel Disease

   • Eun Jin Jang
   • Jung Eun Ha
   • Hyun Soon Sohn

   Original Research Article 16 May 2019 Pages: 625 - 630

   

4. Effect of Sodium Glucose Co-Transporter 2 Inhibitors on Liver Fat Mass and Body Composition in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus

   • Yoshitaka Arase
   • Koichi Shiraishi
   • Tatehiro Kagawa

   Original Research Article Open access 16 April 2019 Pages: 631 - 641

   

5. Safety, Pharmacokinetics, and Pharmacogenetics of Single-Dose Teriflunomide Sodium and Leflunomide in Healthy Chinese Subjects

   • Xueting Yao
   • Yiwen Wu
   • Xia Chen

   Original Research Article 23 April 2019 Pages: 643 - 651

   

6. Effectiveness of an Intervention to Improve Management of COPD using the AUDIT Methodology: Results of the Neumo-Advance Study

   • Javier de Miguel-Díez
   • Rodrigo Jiménez-García
   • Fernando Zaragoza Arnáez

   Original Research Article 29 April 2019 Pages: 653 - 664

7. Comparison of Safety Profiles of New Oral Anticoagulants with Warfarin Using the Japanese Spontaneous Reporting Database

   • Keiko Hosohata
   • Saki Oyama
   • Kazunori Iwanaga

   Original Research Article 03 May 2019 Pages: 665 - 670

8. Safety, Tolerability and Pharmacokinetics of Yimitasvir Phosphate Capsule, a Novel Oral Hepatitis C Virus NS5A Inhibitor, in Healthy Chinese Volunteers

   • Nan Zhao
   • Ran Xie
   • Yimin Cui

   Original Research Article 11 May 2019 Pages: 671 - 681

   

9. Adverse Drug Reaction Profile of SGLT2 Inhibitor-Associated Diabetic Ketosis/Ketoacidosis in Singapore and their Precipitating Factors

   • Michael Limenta
   • Christine S. C. Ho
   • Dorothy S. L. Toh

   Original Research Article Open access 07 May 2019 Pages: 683 - 690

   

10. Rifamycin SV MMX^®: A Review in the Treatment of Traveller’s Diarrhoea

    • Sheridan M. Hoy

    Adis Drug Evaluation 07 June 2019 Pages: 691 - 697

11. Correction to: Rifamycin SV MMX^®: A Review in the Treatment of Traveller’s Diarrhoea

    • Sheridan M. Hoy

    Correction 20 June 2019 Pages: 699 - 699

12. Correction to: Comparison of the Efficacy and Safety of Tofacitinib and Apremilast in Patients with Active Psoriatic Arthritis: A Bayesian Network Meta-Analysis of Randomized Controlled Trials

    • Gwan Gyu Song
    • Young Ho Lee

    Correction 13 June 2019 Pages: 701 - 701